The increasing utilization of these immune checkpoint inhibitors has presented new of immune-related adverse events that have proven to be extremely challenging to manage.
Marley L. Watson, PharmD, BCOP
Advertisement
Articles by Marley L. Watson, PharmD, BCOP
Advertisement
Latest Updated Articles
Management of Steroid-Refractory Immune-Related Adverse EventsPublished: August 23rd 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Anti-TIGIT Combination Therapy Yields Positive Survival in Gastric Cancers
2
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
3
Bridging Radiotherapy Prior to CAR T May Be Safe in R/R Multiple Myeloma
4
Debate Round 3: Timing of Treatment Initiation in LR-MDS (Earlier vs Delayed)
5
